# Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions

> **NCT00778544** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** amoxicillin-clavulanic acid 600 mg- 42.9 mg/ 5 mL oral suspension

## Key facts

- **NCT ID:** NCT00778544
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-07
- **Final completion:** 2006-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2008-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778544, "Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00778544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*